Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

174 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Among authors: Schleinitz N. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Among authors: Schleinitz N. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: a classic skin rash with a necrotizing myositis and high risk of malignancy.
Monseau G, Landon-Cardinal O, Stenzel W, Schoindre Y, Mariampillai K, Barete S, Martel C, Masseau A, Meyer A, Terrier B, Guégan S, Verneuil L, Audia S, Livideanu CB, Hachulla E, Kahn JE, Lefevre G, Maurier F, Moulis G, Papo T, Dossier A, Descamps V, Salort-Campana E, Richard MA, Bergot E, Mortier L, Costedoat-Chalumeau N, Genot S, Perez F, Piette AM, Samson M, Schleinitz N, Zénone T, Lacoste M, de Boysson H, Madaule S, Rigolet A, Champtiaux N, Hervier B, Bouvier AM, Jooste V, Léonard-Louis S, Maisonobe T, Aouba A, Benveniste O, Bienvenu B, Allenbach Y; French Myositis Network. Monseau G, et al. Among authors: Schleinitz N. J Am Acad Dermatol. 2020 Mar 31:S0190-9622(20)30480-1. doi: 10.1016/j.jaad.2020.03.058. Online ahead of print. J Am Acad Dermatol. 2020. PMID: 32244015 No abstract available.
IgG4 hypophysitis: diagnosis and management.
Lojou M, Bonneville JF, Ebbo M, Schleinitz N, Castinetti F. Lojou M, et al. Among authors: Schleinitz N. Presse Med. 2020 Mar 28:104016. doi: 10.1016/j.lpm.2020.104016. Online ahead of print. Presse Med. 2020. PMID: 32234384 French. No abstract available.
Pathophysiology of IgG4-related disease: a T follicular helper cells disease?
De Sainte Marie B, Urban ML, Vély F, Seguier J, Grados A, Daniel L, Ebbo M, Schleinitz N. De Sainte Marie B, et al. Among authors: Schleinitz N. Presse Med. 2020 Mar 28:104013. doi: 10.1016/j.lpm.2020.104013. Online ahead of print. Presse Med. 2020. PMID: 32234383 French. No abstract available.
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis.
Charles P, Dechartres A, Terrier B, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Mouthon L, Guillevin L; French Vasculitis Study Group. Charles P, et al. Rheumatology (Oxford). 2020 Mar 9:kez621. doi: 10.1093/rheumatology/kez621. Online ahead of print. Rheumatology (Oxford). 2020. PMID: 32150263
Comment on article: 'Dupilumab as a novel steroid-sparing treatment for IgG4-related disease' by Simpson et al.
Ebbo M, De Sainte-Marie B, Muller R, Piperoglou C, Grados A, Vély F, Schleinitz N. Ebbo M, et al. Among authors: Schleinitz N. Ann Rheum Dis. 2020 Jan 29:annrheumdis-2020-217010. doi: 10.1136/annrheumdis-2020-217010. Online ahead of print. Ann Rheum Dis. 2020. PMID: 31996366 No abstract available.
"Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients.
Lefèvre G, Leurs A, Gibier JB, Copin MC, Staumont-Sallé D, Dezoteux F, Chenivesse C, Lopez B, Terriou L, Hachulla E, Launay D, Etienne N, Labalette M, DeGroote P, Pontana F, Quemeneur T, Hatron PY, Schleinitz N, Viallard JF, Hamidou M, Martin T, Morati-Hafsaoui C, Groh M, Lambert M, Kahn JE; CEREO—French National Reference Center for Hypereosinophilic Syndromes. Lefèvre G, et al. Among authors: Schleinitz N. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1329-1340.e3. doi: 10.1016/j.jaip.2019.12.011. Epub 2019 Dec 18. J Allergy Clin Immunol Pract. 2020. PMID: 31863912
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.
Roupie AL, de Boysson H, Thietart S, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Decaux O, d'Aveni M, Rossignol J, Galland J, Solary E, Willems L, Schleinitz N, Ades L, Dellal A, Samson M, Aouba A, Fenaux P, Fain O, Mekinian A; On behalf MINHEMON (French Network of dysimmune disorders associated with hemopathies). Roupie AL, et al. Among authors: Schleinitz N. Autoimmun Rev. 2020 Feb;19(2):102446. doi: 10.1016/j.autrev.2019.102446. Epub 2019 Dec 13. Autoimmun Rev. 2020. PMID: 31838164 Review.
[Systemic sclerosis and macrovascular involvement: Status of the issue in 2019].
Bertolino J, Scafi M, Benyamine A, Aissi K, Boufi M, Schleinitz N, Sarlon G, Rossi P, Granel B. Bertolino J, et al. Among authors: Schleinitz N. J Med Vasc. 2019 Dec;44(6):400-421. doi: 10.1016/j.jdmv.2019.09.002. Epub 2019 Sep 28. J Med Vasc. 2019. PMID: 31761307 Review. French.
174 results
Jump to page
Feedback